» Articles » PMID: 11391162

Provider Assessment of Adherence to HIV Antiretroviral Therapy

Overview
Date 2001 Jun 8
PMID 11391162
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Adherence assessment is an essential component of monitoring HIV antiretroviral therapy. Prior studies suggest that medical providers frequently estimate individual patient adherence inaccurately.

Objective: We compared provider estimates of nonadherence to antiretroviral therapy with unannounced pill counts and structured patient interviews to determine the accuracy of adherence information obtained by providers and patients.

Design, Setting, And Participants: Comparison of three adherence measures in homeless or marginally housed persons receiving HIV antiretroviral therapy (n = 45) and their providers (n = 35).

Measurements: Provider estimate of percentage of pills taken; three successive patient structured reports of number of doses missed in the last 3 days; and three successive unannounced pill counts.

Results: 13% (95% confidence interval [CI], 4%-22%) of patients were not following their regimen as directed. Provider-adherence estimate explained only 26% (95% CI, 6%-47%) of the variation in pill count adherence, whereas patient report explained 72% (95% CI, 52%-96%). The sensitivity and specificity of provider estimates of nonadherence, defined as <80% of pills taken by pill count, were 40% and 85%, respectively. The sensitivity and specificity of patient interview were 72% and 95%, respectively.

Conclusions: Provider estimate of adherence was inaccurate whereas structured patient report was more closely related to pill count. Structured assessment over several short intervals may improve accuracy of adherence assessment in clinical practice.

Citing Articles

Proinflammatory Biomarkers and Clinical Factors Associated with Long-Term Mortality in People with HIV.

Lembas A, Zaleski A, Mikula T, Kozlowska J, Wiercinska-Drapalo A Viruses. 2025; 17(2).

PMID: 40006998 PMC: 11860511. DOI: 10.3390/v17020243.


Managing Modern Antiretroviral Therapy in the Intensive Care Unit: Overcoming Challenges for Critically Ill People With Human Immunodeficiency Virus.

Chastain D, Tu P, Brizzi M, Keedy C, Baker A, Jackson B Open Forum Infect Dis. 2024; 11(5):ofae213.

PMID: 38715574 PMC: 11075789. DOI: 10.1093/ofid/ofae213.


Accuracy of measures for antiretroviral adherence in people living with HIV.

Smith R, Villanueva G, Probyn K, Sguassero Y, Ford N, Orrell C Cochrane Database Syst Rev. 2022; 7:CD013080.

PMID: 35871531 PMC: 9309033. DOI: 10.1002/14651858.CD013080.pub2.


Effect of suicidality on clinical and behavioural outcomes in HIV positive adults in Uganda.

Rukundo G, Levin J, Mpango R, Patel V, Kinyanda E PLoS One. 2021; 16(8):e0254830.

PMID: 34415901 PMC: 8378732. DOI: 10.1371/journal.pone.0254830.


Quality of antiretroviral therapy services in Ghana: Implications for the HIV response in resource-constrained settings.

Alhassan R, Ketor C, Ashinyo A, Ashinyo M, Nutor J, Adjadeh C SAGE Open Med. 2021; 9:20503121211036142.

PMID: 34377475 PMC: 8326618. DOI: 10.1177/20503121211036142.